scispace - formally typeset
A

Amit K. Goyal

Researcher at Central University of Rajasthan

Publications -  157
Citations -  7166

Amit K. Goyal is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Drug delivery & Drug carrier. The author has an hindex of 47, co-authored 157 publications receiving 5749 citations. Previous affiliations of Amit K. Goyal include Council of Scientific and Industrial Research & Central Electronics Engineering Research Institute.

Papers
More filters
Journal ArticleDOI

Permeation enhancer strategies in transdermal drug delivery

TL;DR: New controlled transdermal drug delivery systems (TDDS) technologies (electrically-based, structure-based and velocity-based) have been developed and commercialized for thetransdermal delivery of troublesome drugs.
Journal ArticleDOI

Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.

TL;DR: The comparative study conducted on methotrexate (MTX)-bearing SLNs revealed that the formulation based on Compritol 888 ATO could noticeably improve the oral bioavailability of MTX, presumably following SLNs constituting lipid digestion and co-absorption through lymphatic transport and route.
Journal ArticleDOI

Recent advances in metal nanoparticles in cancer therapy

TL;DR: This review addresses the advancement of metal NPs in tumour therapy with a focus on those being explained into clinical settings.
Journal ArticleDOI

Advanced drug delivery approaches against periodontitis

TL;DR: Control local drug delivery approach is more favorable as compared to systemic approach because it mainly focuses on improving the therapeutic outcomes by achieving factors like site-specific delivery, low dose requirement, bypass of first-pass metabolism, reduction in gastrointestinal side effects and decrease in dosing frequency.
Journal ArticleDOI

Biomaterial-based scaffolds – current status and future directions

TL;DR: In the future, the main focus will be on the development of more patient compliant, sustained and controlled delivery systems against various diseases by modification of polymers, manufacturing technologies as well as carrier systems.